Key facts
- This page summarizes Robert Ho's Form 4 filing for Third Harmonic Bio, Inc. (THRD).
- 5 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 08 Mar 2023, 15:58.
Robert Ho - 06 Mar 2023 Form 4 Insider Report for Third Harmonic Bio, Inc. (THRD)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- THRD
- Reported as of
- 06 Mar 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 08 Mar 2023, 15:58:48 UTC
- Prior SEC filing
- 27 Oct 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Robert Ho
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Robert Ho filed Form 4 for Third Harmonic Bio, Inc. (THRD) on 08 Mar 2023.
Change
- Previous filing in this sequence was filed on 27 Oct 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
THRD
transaction
Derivative
Employee Stock Option (right to buy)
Disposed to Issuer
- Transaction value
- Shares
- -367,955
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 06 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 367,955
- Exercise price
- $9.22
- Footnotes
- F1, F2
THRD
transaction
Derivative
Employee Stock Option (right to buy)
Award
- Transaction value
- Shares
- +367,955
- Change %
- Price
- Shares after
- 367,955
- Date
- 06 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 367,955
- Exercise price
- $4.20
- Footnotes
- F1, F2
THRD
transaction
Derivative
Employee Stock Option (right to buy)
Disposed to Issuer
- Transaction value
- Shares
- -95,000
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 06 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 95,000
- Exercise price
- $18.40
- Footnotes
- F1, F3
THRD
transaction
Derivative
Employee Stock Option (right to buy)
Award
- Transaction value
- Shares
- +95,000
- Change %
- Price
- Shares after
- 95,000
- Date
- 06 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 95,000
- Exercise price
- $4.20
- Footnotes
- F1, F3
THRD
transaction
Derivative
Employee Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +136,000
- Change %
- Price
- $0.000000
- Shares after
- 136,000
- Date
- 06 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 136,000
- Exercise price
- $4.20
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The transaction reported herein reflects a one-time stock option repricing that became effective on March 6, 2023, and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options.
Footnote F2
25% of the total shares vested on March 7, 2023, and thereafter 6.25% of the total shares underlying the award shall vest in equal quarterly installments until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
Footnote F3
The option vests over a four-year period: 1/48th on November 25, 2022, after which 1/48th of the total shares vest monthly, subject to continued service through each vesting date.
Footnote F4
The option vests over a four-year period: 1/48th on April 6, 2023, after which 1/48th of the total shares vest monthly, subject to continued service through each vesting date.